Latest News:
13.01.2011
XL-protein Collaborates with Phylogica on Inflammation Program
05.10.2010
XL-protein wins Universal Biotech "Innovation Prize 2010"
News
September, 18- Many biopharmaceuticals comprise small proteins that are quickly eliminated from the body. Scientists at the Technische Universitaet Muenchen (TUM) combine such small proteins with a kind of molecular balloon that swells and thus prolongs the half-life of these proteins in the body. The TUM spin-off XL-protein GmbH has now started to further develop this new technology with blockbuster potential.

